PHIBROMONENSIN 200 MONENSIN FEED ADDITIVE PREMIX

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:

MONENSIN AS MONENSIN SODIUM

Available from:

PHIBRO ANIMAL HEALTH PTY LIMITED

INN (International Name):

monensin as sodium(200g/kg)

Pharmaceutical form:

ORAL POWDER, PRE-MIX

Composition:

MONENSIN AS MONENSIN SODIUM ANTIPROTOZOAL Active 200.0 g/kg

Units in package:

25kg

Class:

VM - Veterinary Medicine

Manufactured by:

PHIBRO ANIMAL HEALTH

Therapeutic group:

CATTLE - 50 TO 150KG LIVEWEIGHT | DAIRY CATTLE | FEEDLOT CATTLE (EXCEPT LACTATING DAIRY C | GOAT | BILLY | BOVINE | BREEDERS | B

Therapeutic area:

NUTRITION & METABOLISM

Therapeutic indications:

IMPROVE FEED EFFICIENCY | IMPROVEMENT OF MILK PRODUCTION | KETOSIS | PREVENTION OF COCCIDIOSIS | ACETONAEMIA | COCCIDIOSIS - PREVENTION OF | ELEVATED KETONES | NON-CLINICAL KETOSIS

Product summary:

Poison schedule: 4; Withholding period: WHP: Cattle: Meat: Nil Milk: Nil Goa ts: Meat: Nil Milk: DO NOT USE PhibroM onensin in goats producing milk for hum an consumption.; Host/pest details: CATTLE - 50 TO 150KG LIVEWEIGHT: [PREVENTION OF COCCIDIOSIS]; DAIRY CATTLE: [IMPROVEMENT OF MILK PRODUCTION, KETOSIS]; FEEDLOT CATTLE (EXCEPT LACTATING DAIRY C: [IMPROVE FEED EFFICIENCY]; GOAT: [PREVENTION OF COCCIDIOSIS]; Poison schedule: 4; Withholding period: ; Host/pest details: CATTLE - 50 TO 150KG LIVEWEIGHT: [PREVENTION OF COCCIDIOSIS]; DAIRY CATTLE: [IMPROVEMENT OF MILK PRODUCTION, KETOSIS]; FEEDLOT CATTLE (EXCEPT LACTATING DAIRY C: [IMPROVE FEED EFFICIENCY]; GOAT: [PREVENTION OF COCCIDIOSIS]; To improve feed efficiency in feedlot cattle (except lactating dairy cows). Increase milk production in dairy cows under some conditions. Aid in reducing the severity of non-clinical ketosis in lactating dairy cows. Aid in the prevention of coccidiosis…DO NOT USE in goats producing milk for human consumption

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

                                Copy in the header
&
footer will not appear on the final printed label
NOTE: Label deletions are marked as
&\r\kel:h,o~gh
and
wHI
not appear on the final
label,
insertions (marked) as underlined
will
appear on the final
label, however they will
not be underlined.
lab~PhibroMonensin200b.doc
Replaces
lab-PhlbroMonensin200a
Product
Number
55526
Prepared:
25/11/2002
Application
Number
.,
"
26400
NRA Approved:
.
Primary Pack
1
Immediate Container Labels
Page 1 of 3
PhibroMonensin 200 mcnenein feed additive premix
SINGLE PANEL
lABEL
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTiONS BEFORE OPENING OR USING
FOR ANIMAL TREATMENT ONLY
PhibroMonensin 200*
monensln feed additive premix
Monensln (as monensin sodium) 200 g/kg
To improve feed efficiency in feedlot
callle (except lactating dairy cows).
To increase milk production in dairy
cows under some conditions.
As an aid in reducing the severity of nonclinical
ketosis in lactating dairy cows.
As an aid in the prevention of coccidiosis in cattle
(E.
zuernii,
E.
bovis)
and goats
(E.
adoingi,
E.
christenseni,
E.
ninakohlyakimovae).
DIRECTIONS
FOR
USE
Restraints
DO NOT USE
PhibroMonensin
In
goats
producing
milk
for
human
consumption.
Precautions
DO NOT
exceed
recommended
levels
of
PhibroMonensin
and do
not
administer
PhlbroMonensin
to
cattle treated
with
a
monensin
containing
anti
bloat
capsule
within
the
previous
100
days.
High
levels
can cause
reduced
feed intake,
poor
growth,
disease and death.
Responses
to
PhibroMonensin
are
unlikely
if
the
nutrient
Intake is
significantly
restricted,
DO NOT
allow
dogs,
horses
or
other
equines
access
to
feeds
containing
PhibroMonensfn.
Ingestion
by
dogs
and
horses
may
be fatal,
As
per
Good
Industry
Practice,
colostrum
and
milk
collected
within
96
hours
(8
mllkings)
after
calving
must
not
be used
for
human
consumption
or
processing.
Feeding
monensin
to
lactating
dairy
cows
may
result
in decreased
milk
fat
percentage,
but
there is no
effect
on total
fat
yield.
PhibroMonensin
must
be
thoroughly
mixed
with
other
fe
                                
                                Read the complete document